1. Balfour DJK and Fagerstrom KO (1996) Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol Ther 72: 51-81

2. McGehee DS and Role LW (1995) Physiological diversity of nicotinic
acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol
57: 521-546

3. Picciotto MR (1998) Common aspects of the action of nicotine and other
drugs of abuse. Drug Alcohol Depend 51: 165-172

4. Ferry LH.. Non-nicotine pharmacotherapy for smoking cessation. Prim
Care. 1999 Sep;26(3):653-69.

5. Kuhar MJ, Central Cholinergic pathways: physiologic and pharmacologic
aspects. Psychopharamacology A Generation of Progress, Raven Press, NY
1978, pp199-204.

6. Kerlavage, AR, et al, Muscarinic cholinergic receptor structure: molecular biological support for subtypes. Trends Pharmacol. Sci., 1987, 8, 426-429.

7. Gillman AG, Rall TW, Taylor P, and Nies AS, Goodman and Gillman’s The
Pharmacologic Basis of Therapeutics, 8th edition, Macmillan Pub, 1990.

8. Ketchum JS, Sidell FR, Crowell EB Jr. Atropine, scopolamine, and ditran: Comparative pharmacology and antagonist in man.
Psychophamacologia, 1973;28:131.

9. Vezina P, Blanc G, Glowinski J and Tassin J-P (1992) Nicotine and
morphine differentially activate brain dopamine in prefrontocortical and
subcortical terminal fields: Effects of acute and repeated injections. J
Pharmacol Exp Ther 261: 484-490

10. Pidoplichko VI, DeBiasi M, Williams JT and Dani JA (1997) Nicotine
activates and desensitizes midbrain dopamine neurons. Nature (Lond) 390:
401-404

11. Nisell M, Nomikos GG and Svensson TH (1994) Systemic nicotine-induced
dopamine release in the rat nucleus accumbens is regulated by nicotinic
receptors in the ventral tegmental area. Synapse 16: 36-44.

12. Barajas-Lopez C, Karanjia R, Espinosa-Luna R. 5-Hydroxytryptamine and
atropine inhibit nicotinic receptors in submucosal neurons. Eur J Pharmacol. 2001 Mar 2;414(2-3):113-23.

13. Schilstrom B, Svensson HM, Svensson TH and Nomikos GG (1998) Nicotine
and food induced dopamine release in the nucleus accumbens of the rat:
Putative role of 7 nicotinic receptors in the ventral tegmental area.
Neuroscience 85: 1005-1009.

14. Nisell M, Nomikos GG and Svensson TH (1995) Nicotine dependence,
midbrain dopamine systems and psychiatric disorders. Pharmacol Toxicol
76: 157-162.

15. Horger BA and Roth RH (1996) The role of mesoprefrontal dopamine
neurons in stress. Crit Rev Neurobiol 10: 395-418.

16. George TP, Verrico CD, Xu L and Roth RH (2000) Effects of repeated
nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral
responses to acute footshock stress: Evidence for opioid mechanisms.
Neuropsychopharmacology 23: 79-88.

17. Hughes JR, Hatsukami DK, Mitchell JE and Dahlgren LA (1986) Prevalence
of smoking among psychiatric outpatients. Am J Psychiatry 143: 993-997.

18. Ziedonis DM and George TP (1997) Schizophrenia and nicotine use:
Report of a pilot smoking cessation program and review of neurobiological
and clinical issues. Schizophr Bull 23: 247-254

19. Yum L, Wolf KM and Chiappinelli VA (1996) Nicotinic acetylcholine
receptors in separate brain regions exhibit different affinities for
methyllycaconitine. Neuroscience 72: 545-555

20. Bachynsky N. The use of anticholinergic drugs for smoking cessation: a
pilot study. Int J Addict. 1986 Jul;21(7):789-805

21. Hill JA, Jr, Zoli M, Bourgeois J-P and Changeaux J-P (1993)
Immunocytochemical localization of a neuronal nicotinic receptor: The 2
subunit. J Neurosci 13: 1551-1568